Rocha RV, Tam DY, Karkhanis R, et al. - Researchers applied propensity score matching in this multicenter population-based study to compare the long-term clinical results of total arterial revascularization (TAR) vs non-TAR [coronary artery bypass grafting (CABG) with at least 1 arterial and 1 saphenous vein graft]. This study was performed from October 2008 to March 2017 in Ontario, Canada. People from out of province and younger than 18 years, and patients undergoing a cardiac reoperation or experiencing a cardiogenic shock were eliminated from the study. Time to first event of a composite of death, myocardial infarction, stroke, or repeated revascularization (major adverse cardiac and cerebrovascular events) was considered as the primary outcome. Findings revealed improved long-term freedom from major adverse cardiac and cerebrovascular events, death, and myocardial infarction in relation to TAR. For patients with reasonable life expectancy needing CABG, TAR may be the procedure of choice.